coroniavaughns@kbin.social to Science@kbin.social · 1 year agoSafety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trialwww.thelancet.comexternal-linkmessage-square0fedilinkarrow-up11arrow-down10cross-posted to: [email protected]
arrow-up11arrow-down1external-linkSafety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trialwww.thelancet.comcoroniavaughns@kbin.social to Science@kbin.social · 1 year agomessage-square0fedilinkcross-posted to: [email protected]
